Dermatomyositis – úvodní projev pokročilého stadia primárního karcinomu ovaria z prstenčitých buněk

English version

Authors: B. Yuksel ¹; N. Erkek ¹; E. Uygur Kucukseymen ¹; G. Ayse Ocak ²;  f. Genc ¹; Y. Bicer Gomceli ¹;  a. Yaman ¹
Authors‘ workplace: Antalya Training and Research Hospital, Antalya, Turkey ¹; Akdeniz Üniversitesi Tıp Fakültesi Tıbbi Patoloji Anabilim Dalı, Antalya, Turkey ²
Published in: Cesk Slov Neurol N 2017; 80(6): 726-729
Category: Letter to Editor
doi: https://doi.org/10.14735/amcsnn2017726

Overview

Autoři deklarují, že v souvislosti s předmětem studie nemají žádné komerční zájmy.

Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.

Sources

1. Chao LW, Wei LH. Dermatomyositis as the initial presentation of ovarian cancer. Taiwan J Obstet Gynecol 2009;48(2):178– 80. doi: 10.1016/ S1028-4559(09)60283-7.

2. Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol 2006;24(5):363– 73. doi: 10.1016/ j.clindermatol.2006. 07.001.

3. Requena C, Alfaro A, Traves V, et al. Paraneoplastic Dermatomyositis: A Study of 12 Cases. Actas Dermosifiliogr 2014;105(7):675– 82. doi: 10.1016/ j.ad.2013.11.007.

4. El-Safadi S, Stahl U, Tinneberg HR, et al. Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review. Case Rep Oncol 2010;3(3):451– 7. doi: 10.1159/ 000323003.

5. Terada T. Signet-Ring Cell Carcinoma of the Eso-phagus in Dermatomyositis: a Case Report with Immunohistochemical Study. J Gastrointest Canc 2013;44 (4):489– 90. doi: 10.1007/ s12029-012-9473-3.

6. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;13;292(7):344– 7. doi: 10.1056/ NEJM197502132920706.

7. Terada T. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases. Int J Clin Exp Pathol 2013;6(4):703– 10.

8. Yamagishi H, Imai Y, Okamura T, et al. Aberrant cyto-keratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma. J Gastroenterol Hepatol 2013;28(12):1815– 22. doi: 10.1111/ jgh.12319.

9. Lundberg IE, Miller FW, Tjärnlund A, et al. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 2016;280(1):39– 51. doi: 10.1111/ joim.12524.

10. Hoogendijk JE, Amato AA, Lecky BR, et al. 119thENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14(5):337– 45. doi: 10.1016/ j.nmd.2004.02.006.